ADOR develops, manufactures and markets unique in-vitro diagnostic solutions.
ADOR Diagnostics has raised $7.5M in total funding. The most recent round was Series B. The last funding was announced in October 2023.
ADOR Diagnostics's investors include BATM Ltd.
ADOR Diagnostics is headquartered in Rome, Italy.
ADOR develops, manufactures and markets unique in-vitro diagnostic solutions.
ADOR Diagnostics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ADOR Diagnostics — Funding & Investors." VCBacked, October 23, 2023, https://www.vcbacked.co/company/ador-diagnostics. Accessed August 14, 2026.
VCBacked. (2023). ADOR Diagnostics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ador-diagnostics
{{cite web |title=ADOR Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/ador-diagnostics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated